Poolbeg Pharma plc – Proposed Retail Offer to raise up to £100,000
Poolbeg Pharma plc (AIM: POLB, ‘Poolbeg Pharma’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, is pleased to announce a retail offer via the BookBuild Platform (the “BookBuild Offer”) of new ordinary shares of 0.02 pence each (the “Ordinary Shares”) in the capital of the Company (the “BookBuild Offer Shares”) to raise gross proceeds of up to £100,000. Pursuant to the BookBuild Offer, up to 4,000,000 BookBuild Offer Shares will be made available at an issue price of 2.5 pence per BookBuild Offer Share (the “Issue Price”).
